AIDS

1. CALCAGNO A, Strano M, Lolatto R, Vercesi R, et al
   Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry.
   AIDS. 2026;40:1045-1049.
   

   >> Share

   
   
2. MOYLE G, Assoumou L, De Castro N, Post FA, et al
   Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutation.
   AIDS. 2026 Jan 23. doi: 10.1097/QAD.0000000000004451.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

3. DEKA N, Brauer AL, Connerton K, Hanson BM, et al
   Pangenome analysis of Proteus mirabilis reveals lineage-specific antimicrobial resistance profiles and discordant genotype-phenotype correlations.
   Antimicrob Agents Chemother. 2026 May 29:e0176825. doi: 10.1128/aac.01768.
   

   >> Share

   
   
4. GONZALEZ-PINTO L, Monge-Olivares L, Perez-Rodriguez G, Aja-Macaya P, et al
   Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D beta-lactamase conferring broad-spectrum beta-lactam resistance in Pseudomonas aeruginosa.
   Antimicrob Agents Chemother. 2026 May 29:e0180525. doi: 10.1128/aac.01805.
   

   >> Share

   
   

   
   Infect Control Hosp Epidemiol

5. WALTERS M, Tracy M, Mollenkopf D, Mathys D, et al
   Clinically important antimicrobial-resistant bacteria present in publicly accessible locations of a tertiary-care hospital.
   Infect Control Hosp Epidemiol. 2026 May 28:1-3. doi: 10.1017/ice.2026.10479.
   

   >> Share

   
   

   
   Int J Antimicrob Agents

6. CAI Y, Lim TP, Lee W, Teo JQ, et al
   The costs and health outcomes associated with a personalised antibiotic combination testing service for carbapenem-resistant Pseudomonas aeruginosa: a cost-effectiveness analysis.
   Int J Antimicrob Agents. 2026 May 24:107852.
   

   >> Share

   
   
7. SHRIRANG PS, Bansal P, Abbot V, Sharma S, et al
   Comment on "Development and validation of a predictive model for profiling antibiotic resistance phenotypes of Acinetobacter baumannii strains via clinical MALDI-TOF mass spectra: A multicenter study".
   Int J Antimicrob Agents. 2026 May 24:107851.
   

   >> Share

   
   
8. HE F, Zhang X, Ye H, Luo J, et al
   Aztreonam-Avibactam for Carbapenem-Resistant Gram-Negative Infections: Mechanisms, Clinical Efficacy, the Challenge of Resistance and Susceptibility Testing.
   Int J Antimicrob Agents. 2026 May 26:107861.
   

   >> Share

   
   
9. OZDEMIR C, Paul T, Egoh K, Wanford JJ, et al
   Burden and Global Distribution of Antimicrobial Resistance in Non-Bloodstream Infections Among Adults with Cirrhosis: A Systematic Review and Proportional Meta-Analysis.
   Int J Antimicrob Agents. 2026 May 27:107849.
   

   >> Share

   
   
10. ASEMPA TE
    Comment on "Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared with Mueller-Hinton broth and artificial cerebrospinal fluid".
    Int J Antimicrob Agents. 2026 May 27:107860.
    

    >> Share

    
    
11. XUE Y, Wang Y, You C, Zheng Y, et al
    Repurposing sulfamethoxazole via gold nanocluster modification for antibacterial and anti-biofilm activity against multidrug-resistant Gram-negative bacteria.
    Int J Antimicrob Agents. 2026;67:107757.
    

    >> Share

    
    
12. HU Y, Yuan L, Xia Z, Wan T, et al
    Characterization of KPC-176, an S171P variant derived from KPC-2, associated with ceftazidime-avibactam resistance in ST11-KL64 Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2026;67:107773.
    

    >> Share

    
    
13. LEE YH, Sulaiman HB, Thamlikitkul V, Lye DC, et al
    Access to new antibacterials in 10 Asian countries: An Asian network for surveillance of resistant pathogens study.
    Int J Antimicrob Agents. 2026;67:107769.
    

    >> Share

    
    
14. ZHANG Q, Xu P, Zhang X, Pi R, et al
    Spontaneous mutations to delamanid and pretomanid resistance in Mycobacterium tuberculosis: SNPs confer high-level resistance.
    Int J Antimicrob Agents. 2026;67:107789.
    

    >> Share

    
    
15. SZETO J, White RT, Perez H, Hardaker A, et al
    Mobile colistin resistance in New Zealand without local agricultural colistin use: Genomic insights into mcr-carrying plasmids and their global context, 1984-2024.
    Int J Antimicrob Agents. 2026;67:107801.
    

    >> Share

    
    

    
    J Antimicrob Chemother

16. HALDORSEN BC, Augustinussen MH, Matuschek E, Smabrekke L, et al
    Performance of EUCAST disc diffusion and supplementary methods to detect reduced susceptibility to linezolid in enterococci- the NordicAST LRE-study.
    J Antimicrob Chemother. 2026;81:dkag174.
    

    >> Share

    
    
17. CANTON R, Garcia-Castillo M, Hernandez-Garcia M, Sastre-Femenia MA, et al
    Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes.
    J Antimicrob Chemother. 2026;81:dkag164.
    

    >> Share

    
    

    
    J Infect Dis

18. ARIAS CA
    The Maxwell Finland Lecture 2025: Antimicrobial Resistance At The Bedside: Translating Science Into Patient Outcomes.
    J Infect Dis. 2026 May 26:jiag273. doi: 10.1093.
    

    >> Share

    
    

    
    JAMA

19. BANERJEE R, Komarow L, Li Y, Mau D, et al
    Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial.
    JAMA. 2026;335:1762-1773.
    

    >> Share

    
    

    
    PLoS One

20. ADHIKARI TB, Muzhinji N, Gaire S, Magar PB, et al
    Genome-wide analysis of the invasive fungal pathogen Neopestalotiopsis reveals high genomic diversity, effector repertoires, and the assessment of fungicide resistance risks.
    PLoS One. 2026;21:e0348782.
    

    >> Share

    
    
21. ARBAB S, Ullah H, Wang W, Shahzad A, et al
    Antimicrobial resistance in Gram-negative bacteria from retail meat: Prevalence and public health implications.
    PLoS One. 2026;21:e0346434.
    

    >> Share

    
    
22. LIN SX, Yeh KS
    Characteristics of Escherichia coli ST131 strains isolated from dogs and cats with urinary tract infections in a teaching hospital in Taiwan.
    PLoS One. 2026;21:e0350088.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

23. MONNAPPA S, Al-Mayyah Z, Sakar MS, Persat A, et al
    Growth in confinement promotes Pseudomonas aeruginosa tolerance to antibiotics.
    Proc Natl Acad Sci U S A. 2026;123:e2605176123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share